Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts
Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Posts navigation Older postsNewer posts